Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Docetaxel In Second-Line Treatment Of Advanced Non-Small-Cell Lung Cancer - The Distal Study

NCT00022022 is registered in ClinicalTrials.gov with Istituto Nazionale per lo Studio e la Cura dei Tumori as lead sponsor.

NCT NCT00022022
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00022022 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Docetaxel In Second-Line Treatment Of Advanced Non-Small-Cell Lung Cancer - The Distal Study
Lead sponsor
Istituto Nazionale per lo Studio e la Cura dei Tumori
Phase
Phase 3
Overall status
Unknown status
Start date
December 31, 2000
Completion date
Not reported
Enrollment
200 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer